KeyBank National Association’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,021
| Closed | -$330K | – | 1077 |
|
|
2023
Q2 | $330K | Buy |
13,021
+391
| +3% | +$9.9K | ﹤0.01% | 852 |
|
|
2023
Q1 | $407K | Sell |
12,630
-2,400
| -16% | -$77.3K | ﹤0.01% | 775 |
|
|
2022
Q4 | $277K | Buy |
15,030
+5,740
| +62% | +$106K | ﹤0.01% | 893 |
|
|
2022
Q3 | $251K | Sell |
9,290
-3,632
| -28% | -$98.1K | ﹤0.01% | 911 |
|
|
2022
Q2 | $179K | Buy |
+12,922
| New | +$179K | ﹤0.01% | 1017 |
|